Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 14Sarcoma 5Other solid neoplasm 3Genitourinary 3Gastrointestinal 3Lymphoid 1Head & Neck 1Gynecologic 1

Conditions

Lymphoma 2Head and Neck Neoplasms 2Wilms Tumor 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Sarcoma 1Retinoblastoma 1Ovarian Neoplasms 1Osteosarcoma 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Medulloblastoma 1Liver Neoplasms 1Kidney Neoplasms 1Fibrosarcoma 1Esthesioneuroblastoma, Olfactory 1Desmoplastic Small Round Cell Tumor 1Dendritic Cell Sarcoma, Interdigitating 1Chondrosarcoma 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1Brain Neoplasms 1Astrocytoma 1

Interventions

Peripheral Blood Stem Cell Transplantation 2Filgrastim 2Cisplatin 2tipifarnib 1entrectinib 1entinostat 1Thiotepa 1Thalidomide 1Temozolomide 1Tamoxifen 1Radiotherapy 1Oxaliplatin 1LY2940680 1Irinotecan 1Fentanyl 1Etoposide 1Doxorubicin 1Docetaxel 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Carmustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Medulloblastoma × Thiotepa × Head & Neck × Clear all
NCT00007982 2013-02-04

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer

National Cancer Institute (NCI)

Phase 2 Completed
30 enrolled
CNSHead & NeckLymphoid

Astrocytoma, Brain Neoplasms, Head and Neck Neoplasms, Lymphoma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡